InterventionsHuman trial52 participants12 weeksRandomised trial

Changes in circulating immune cells and cytokines after high-intensity aerobic exercise in patients with prostate cancer undergoing active surveillance from the ERASE randomized controlled trial

Figure 1. Adjusted between-group differences in circulating immune measures after 12 weeks of HIIT versus usual care (ERASE trial).
Open the figure at full size
Figure 1. Adjusted between-group differences in circulating immune measures after 12 weeks of HIIT versus usual care (ERASE trial).Adjusted between-group differences in circulating immune measures after 12 weeks of HIIT versus usual care (ERASE trial).Kang et al.

Frontiers in Immunology

The paper

Kang DW, Patel D, Field CJ et al.

Frontiers in Immunology · 7 Sep 2026

doi.org/10.3389/fimmu.2026.1923463PubMed 42769245